CagriSema Prices

Also known as Cagrilintide/semaglutide; NNC0174-0833

2 listings from 2 vendors, normalised to one honest price per milligram.

Cheapest per mg
$7.10
per mg, lowest listed
At
Corex Vitality™
lowest listed price
Vendors
2
2 listings
Sizes
10 mg
1 size
Compare

CagriSema price per mg by vendor

Prices last collected November 21, 2026. Prices change often - check the vendor's site before ordering.

Choose a size to compare vendor prices.

Price history

Is CagriSema getting cheaper?

The same products from the same vendors, same size and in stock on both days, compared with the first day we tracked. Each vendor counts once.

+14.9%
pricier between Aug 27 and Sep 28, like for like
2 of 3vendors changed a price
32days tracked
0%+5%+10%32 days ago16 days agoToday

CagriSema prices went up 14.9% between Aug 27 and Sep 28, like for like. Too few of the products compared are still sold to carry the line to today. 2 of 3 vendors compared changed a price.

% change since the first tracked day. Hover or tap for detail. Listed prices, not what anyone paid. Compare with the market

Mixing

Mixing CagriSema

What each amount of water produces at this vial size. Educational reference, not a recommendation.

1mL
10.00 mg/mL
2mL
5.00 mg/mL
3mL
3.33 mg/mL

Vial sizes are the ones vendors list for CagriSema. Work out any other combination in the reconstitution calculator.

About

About CagriSema

What it is

CagriSema is an investigational once-weekly injectable that combines the amylin analog cagrilintide with the glucagon-like peptide-1 receptor agonist semaglutide in a single product. It has completed phase 3 trials for chronic weight management and type 2 diabetes, and a new drug application has been filed with the FDA. It is not yet approved, and regulatory review is ongoing.

How it works

It pairs an amylin receptor agonist with a GLP-1 receptor agonist to reduce appetite and food intake through two complementary pathways.

Researched for

Obesity; weight management; type 2 diabetes

Half-life

Not established

Familiarity

Intermediate

Research evidence

Human trials - phase 2 or 3

Regulatory status

Phase 3

Key risk

The semaglutide component carries a boxed warning for thyroid C-cell tumors and is contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Disclosure. Some vendors above are Peptul partners and pay us a commission when you buy through our link. Rows are ordered by: Peptul partners first, then what is in stock, then single vials before multi-vial packs, then price per milligram. Paying us moves a vendor up this order and changes nothing else - not their trust tier, COA badge, Peptul Score or reviews, which come from evidence and are worked out the same way for everyone. Available discount codes are shown beside the prices above. Discounted prices require the displayed code where indicated.

For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.